CSS
CELG

Cubist Systematic Strategies’s Celgene Corp CELG Stock Holding History

Cubist Systematic Strategies’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-101,649
Closed -$9.4M – 2688
2019
Q2 		$9.4M Buy
101,649
+19,562
+24% +$1.86M 0.17% 130
2019
Q1 		$7.74M Buy
82,087
+58,994
+255% +$5.16M 0.25% 55
2018
Q4 		$1.48M Sell
23,093
-101,236
-81% -$7.47M 0.07% 392
2018
Q3 		$11.1M Buy
124,329
+99,954
+410% +$8.83M 0.61% 12
2018
Q2 		$1.94M Buy
24,375
+12,101
+99% +$1M 0.1% 258
2018
Q1 		$1.09M Sell
12,274
-7,967
-39% -$765K 0.06% 390
2017
Q4 		$2.11M Buy
20,241
+10,241
+102% +$1.16M 0.11% 208
2017
Q3 		$1.46M Buy
+10,000
New +$1.36M 0.08% 272
2017
Q2 		– Sell
-5,382
Closed -$670K – 2053
2017
Q1 		$670K Sell
5,382
-23,807
-82% -$2.85M 0.05% 515
2016
Q4 		$3.38M Buy
29,189
+10,527
+56% +$1.17M 0.27% 54
2016
Q3 		$1.95M Sell
18,662
-35,250
-65% -$3.82M 0.13% 207
2016
Q2 		$5.32M Buy
53,912
+17,914
+50% +$1.85M 0.31% 35
2016
Q1 		$3.6M Buy
35,998
+16,893
+88% +$1.74M 0.21% 92
2015
Q4 		$2.29M Sell
19,105
-11,375
-37% -$1.32M 0.13% 182
2015
Q3 		$3.3M Sell
30,480
-71,012
-70% -$8.81M 0.17% 108
2015
Q2 		$11.7M Buy
101,492
+60,485
+147% +$6.91M 0.57% 8
2015
Q1 		$4.73M Sell
41,007
-39,026
-49% -$4.66M 0.23% 79
2014
Q4 		$8.95M Buy
80,033
+51,333
+179% +$5.41M 0.48% 13
2014
Q3 		$2.72M Sell
28,700
-17,911
-38% -$1.62M 0.17% 142
2014
Q2 		$4M Buy
+46,611
New +$3.54M 0.24% 84

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cubist Systematic Strategies's CELG Position: Q3 2019 in Review

Cubist Systematic Strategies sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 101,649 shares — an estimated $9.4M sold.

Cubist Systematic Strategies first reported a position in CELG in Q2 2014 and held it in 20 quarters. The position peaked at $11.7M in Q2 2015. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Cubist Systematic Strategies reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Cubist Systematic Strategies sold 101,649 Celgene Corp shares in Q3 2019, an estimated $9.4M.
  • Cubist Systematic Strategies first reported a position in Celgene Corp in Q2 2014 and held it in 20 quarters.
  • Cubist Systematic Strategies's Celgene Corp position peaked at $11.7M in Q2 2015.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Cubist Systematic Strategies's 13F filing for Q3 2019, filed 14 Nov 2019.